BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34486570)

  • 21. Allopurinol reverses mercaptopurine-induced hypoglycemia in patients with acute lymphoblastic leukemia.
    Zhang M; Bostrom B
    F1000Res; 2019; 8():176. PubMed ID: 30828444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy.
    Adam de Beaumais T; Fakhoury M; Medard Y; Azougagh S; Zhang D; Yakouben K; Jacqz-Aigrain E
    Br J Clin Pharmacol; 2011 Apr; 71(4):575-84. PubMed ID: 21395650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antagonism by methotrexate on mercaptopurine disposition in lymphoblasts during up-front treatment of acute lymphoblastic leukemia.
    Dervieux T; Hancock ML; Pui CH; Rivera GK; Sandlund JT; Ribeiro RC; Boyett J; Evans WE; Relling MV
    Clin Pharmacol Ther; 2003 Jun; 73(6):506-16. PubMed ID: 12811360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Retrospective Review of Mercaptopurine Metabolism Reveals High Rate of Patients With Suboptimal Metabolites Successfully Corrected With Allopurinol.
    Vasta LM; Zanetti RC; Parekh DS; Warwick AB; Lieuw K
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):e1003-e1009. PubMed ID: 32925411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Addition of Allopurinol for Altering Thiopurine Metabolism to Optimize Therapy in Patients with Inflammatory Bowel Disease.
    Wall GC; Muktar H; Effken C; Mahajan PB
    Pharmacotherapy; 2018 Feb; 38(2):259-270. PubMed ID: 29197117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initial clinical experience with allopurinol-thiopurine combination therapy in pediatric inflammatory bowel disease.
    Rahhal RM; Bishop WP
    Inflamm Bowel Dis; 2008 Dec; 14(12):1678-82. PubMed ID: 18521913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.
    Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K
    Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SERS spectroscopy as a tool for the study of thiopurine drug pharmacokinetics in a model of human B leukemia cells.
    Pagarin S; Bolognese A; Fornasaro S; Franzin M; Hofmann U; Lucafò M; Franca R; Schwab M; Stocco G; Decorti G; Bonifacio A
    Chem Biol Interact; 2024 Jan; 387():110792. PubMed ID: 37944627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of red blood cell thiopurine metabolites in children with acute lymphoblastic leukemia who received oral mercaptopurine twice daily or once daily: a Pediatric Oncology Group study (now The Children's Oncology Group).
    Bell BA; Brockway GN; Shuster JJ; Erdmann G; Sterikoff S; Bostrom B; Camitta BM;
    Pediatr Blood Cancer; 2004 Aug; 43(2):105-9. PubMed ID: 15236274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine.
    Hawwa AF; Millership JS; Collier PS; Vandenbroeck K; McCarthy A; Dempsey S; Cairns C; Collins J; Rodgers C; McElnay JC
    Br J Clin Pharmacol; 2008 Oct; 66(4):517-28. PubMed ID: 18662289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increments in DNA-thioguanine level during thiopurine-enhanced maintenance therapy of acute lymphoblastic leukemia.
    Larsen RH; Utke Rank C; Grell K; Nørgaard Møller L; Malthe Overgaard U; Kampmann P; Nersting J; Degn M; Nygaard Nielsen S; Holst H; Klug Albertsen B; Skov Wehner P; Thude Callesen M; Kanerva J; Leth Frandsen T; Als-Nielsen B; Lyngsie Hjalgrim L; Schmiegelow K
    Haematologica; 2021 Nov; 106(11):2824-2833. PubMed ID: 34047177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transport and metabolism of 6-thioguanine and 6-mercaptopurine in mouse small intestine.
    Bronk JR; Lister N; Shaw MI
    Clin Sci (Lond); 1988 Jun; 74(6):629-38. PubMed ID: 3396300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Individualizing therapy with 6-mercaptopurine and 6-thioguanine related to the thiopurine methyltransferase genetic polymorphism.
    Lennard L; Lilleyman JS
    Ther Drug Monit; 1996 Aug; 18(4):328-34. PubMed ID: 8857546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maintenance therapy of childhood acute lymphoblastic leukemia revisited-Should drug doses be adjusted by white blood cell, neutrophil, or lymphocyte counts?
    Schmiegelow K; Nersting J; Nielsen SN; Heyman M; Wesenberg F; Kristinsson J; Vettenranta K; Schrøeder H; Weinshilboum R; Jensen KL; Grell K; Rosthoej S
    Pediatr Blood Cancer; 2016 Dec; 63(12):2104-2111. PubMed ID: 27447547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HPLC determination of thiopurine nucleosides and nucleotides in vivo in lymphoblasts following mercaptopurine therapy.
    Dervieux T; Chu Y; Su Y; Pui CH; Evans WE; Relling MV
    Clin Chem; 2002 Jan; 48(1):61-8. PubMed ID: 11751539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of allopurinol on 6-mercaptopurine metabolism in unselected patients with pediatric acute lymphoblastic leukemia: a prospective phase II study.
    Källström J; Niinimäki R; Fredlund J; Vogt H; Korhonen L; Castor A; Palle J; Harila A; Borssén M; Abrahamsson J; Ek T
    Haematologica; 2024 Feb; ():. PubMed ID: 38356449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylated metabolites of 6-mercaptopurine are associated with hepatotoxicity.
    Nygaard U; Toft N; Schmiegelow K
    Clin Pharmacol Ther; 2004 Apr; 75(4):274-81. PubMed ID: 15060506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mercaptopurine vs thioguanine for the treatment of acute lymphoblastic leukemia.
    Evans WE; Relling MV
    Leuk Res; 1994 Nov; 18(11):811-4. PubMed ID: 7967707
    [No Abstract]   [Full Text] [Related]  

  • 39. Thiopurines with low-dose allopurinol (ThiLDA)-a prospective clinical one-way crossover trial.
    Chavoushi SF; Jharap B; Friedrich P; Smid K; Peters GJ; Malingré M
    Eur J Clin Pharmacol; 2019 Dec; 75(12):1669-1674. PubMed ID: 31587102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allopurinol might improve response to azathioprine and 6-mercaptopurine by correcting an unfavorable metabolite ratio.
    Gardiner SJ; Gearry RB; Burt MJ; Chalmers-Watson T; Chapman BA; Ross AG; Stedman CA; Huelsen A; Barclay ML
    J Gastroenterol Hepatol; 2011 Jan; 26(1):49-54. PubMed ID: 21175793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.